Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Sundays are for bracing for the February half-term week here in the UK, during which schools are closed and parents must ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Communicative ability after stroke influences patient outcomes. Limited research has explored the impact of aphasia when it intersects with cultural or linguistic differences on receiving stroke care ...

Amid a historically unprecedented barrage of executive orders, the key question is: Does the president have the power to ...

The primary end point was a composite of adverse neurovascular events (multiple vessel cervical artery dissection, ischemic stroke, intracerebral hemorrhage, and any neurovascular intervention) at 5- ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

A visit to resistance-held Karen State reveals the impact of four years of war, and the determination of ordinary citizens to ...

To combat heart disease, health innovators are focusing on making healthcare institutions more trustworthy to the needs of ...

Our ThinkStation PX review unit is an exceptional machine, featuring dual Intel Xeon Gold 5420+ processors (28 cores and 56 ...